We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Takeda and Orexigen’s Weight Loss Drug Gets FDA OK
Takeda and Orexigen’s Weight Loss Drug Gets FDA OK
The FDA has cleared Takeda and Orexigen Therapeutics’ weight-loss drug Contrave, the first new anti-obesity product to win approval in more than two years.